Aurora Cannabis was founded in Canada in 2016 by a group of investors, who were able to secure a plot of over 160 acres of land in Mountain View County, where the company’s first facility was located. The company was licensed to grow cannabis in 2014, making it the first cannabis producer to obtain a federal license in that province. On November 2014, Aurora Cannabis was issued the first Health Canada license for the sale of medical marijuana.
Since then, the company has built numerous facilities in Canada, Europe, Asia, Latin America, and Oceania. On January, 2017, the company also received a Health Canada license to sell cannabis oils, prompting the launch of four cannabis oil-based product lines in April 2017. By the end of September 2018, Aurora Cannabis had eight licensed manufacturing facilities, five sale licenses, and operated in 25 countries. Within a year, the declared production capacity grew to over 625,000 kilograms of cannabis per year, most of which taking place at the Canadian headquarters. The presence of Aurora Cannabis on the international markets continued to grow, and today the company is fully operational in 25 countries worldwide.
Aurora ranks fifth among the largest cannabis companies in the world by market capitalisation. As of April 2018, the company had a market value of $ 4.5 billion. At the time, the company was completing the acquisition of its previous competitor CanniMed Therapeutics.